Aandeel 600998 JOINTOWN PHARMACEUTICAL GROUP CO., LTD
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Jointown Pharmaceutical Group Co., Ltd

Aandelen

600998

CNE100000W45

slotkoers Shanghai S.E.
Andere beurzen
 00:00:00 01-07-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
5,01 CNY +2,66% Intraday-grafiek van Jointown Pharmaceutical Group Co., Ltd +0,20% -7,80%
18/06 Jointown Pharmaceutical Group Co, Ltd (SHSE:600998) kondigt een aandeleninkoopprogramma aan voor CNY 300 miljoen aan aandelen. CI
17/06 Jointown Pharmaceutical Group Co, Ltd keurt een terugkoopplan goed. CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!
Gratis inschrijven
Jointown Pharmaceutical Group Co., Ltd announces an Equity Buyback for CNY 300 million worth of its shares.
Jointown Pharmaceutical Group Co., Ltd authorizes a Buyback Plan.
Jointown Pharma's Q1 Profit, Revenue Fall 4%
Jointown Pharmaceutical Group's 2023 Profit Jumps 4%
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Jointown Pharmaceutical Sets Up Joint AI Lab with Peking University's Wuhan Campus
Jiuzhoutong Pharmaceutical Investment Co., Ltd. announced that it expects to receive CNY 10.9100689 billion in funding from Jointown Pharmaceutical Group Co., Ltd
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Jointown Pharma's Unit Gets Nod for Registration of Acarbose Tablets
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Nanjing IASO Biotherapeutics announced that it has received funding from Shanghai Chuanghehui Investment Management Co., Ltd., Jointown Pharmaceutical Group Co., Ltd
Fujian Fukang Pharmaceutical Co., Ltd. announced that it has received funding from Shaoxing Shangyu Hangzhou Bay Economic Development Zone Holding Group Co., Ltd., Jointown Pharmaceutical Group Co., Ltd
Jointown Pharmaceutical Group Co., Ltd announces decision of Regulatory Authority on the transaction
Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.
Jointown Pharmaceutical Group Co., Ltd's Equity Buyback announced on April 26, 2022, has expired with 36,138,098 shares, representing 1.94% for CNY 425.67 million.
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.
Jointown Pharmaceutical Group Co., Ltd announced that it expects to receive CNY 2.33 billion in funding
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers 600998
  4. Nieuws Jointown Pharmaceutical Group Co., Ltd
  5. Andere talen